BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 17387930)

  • 41. Markers of cell-mediated immunity after vaccination with an inactivated, whole-cell Q fever vaccine.
    Izzo AA; Marmion BP; Worswick DA
    J Infect Dis; 1988 Apr; 157(4):781-9. PubMed ID: 3346570
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Comparative studies on immunomodulation via hyperfractionated whole-body irradiation].
    Dietz R
    Strahlenther Onkol; 1991 Aug; 167(8):461-4. PubMed ID: 1887362
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Reactogenic activity of C. burneti vaccines. I. Allergenic and toxic properties of phases I and II C. burneti corpuscular vaccines].
    Crăcea E; Zarnea G; Dumitresco S; Novac S
    Arch Roum Pathol Exp Microbiol; 1968 Sep; 27(3):665-78. PubMed ID: 5742338
    [No Abstract]   [Full Text] [Related]  

  • 44. [Reactogenic activity of C. burneti vaccines. II. Attempts to separate the protecting potency from the toxic and allergenic effects of phase I C. burneti vaccine].
    Crăcea E; Zarnea G; Dumitresco S; Novac S
    Arch Roum Pathol Exp Microbiol; 1968 Sep; 27(3):679-90. PubMed ID: 5742339
    [No Abstract]   [Full Text] [Related]  

  • 45. Effectiveness of hypoglycemic agents in guinea pigs exposed to mixed gamma-neutron radiations.
    Davis LW; Brown JA; Strike TA
    Radiat Res; 1968 Dec; 36(3):622-8. PubMed ID: 17387893
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Dynamics of the humoral immunity indices in laboratory animals multiply infected with Coxiella burnetii].
    Tokarevich NK
    Tr Inst Im Pastera; 1983; 60():64-73. PubMed ID: 6670107
    [No Abstract]   [Full Text] [Related]  

  • 47. [Immunogenicity of an R. burneti strain isolated in Bulgaria].
    Pandŭrov S
    Vet Med Nauki; 1980; 17(1):90-4. PubMed ID: 7414937
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Standardized guinea pig model for Q fever vaccine reactogenicity.
    Baeten LA; Podell BK; Sluder AE; Garritsen A; Bowen RA; Poznansky MC
    PLoS One; 2018; 13(10):e0205882. PubMed ID: 30312355
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An O-Specific Polysaccharide/Tetanus Toxoid Conjugate Vaccine Induces Protection in Guinea Pigs against Virulent Challenge with
    Graves SR; Islam A; Webb LD; Marsh I; Plain K; Westman M; Conlan XA; Carbis R; Toman R; Stenos J
    Vaccines (Basel); 2022 Aug; 10(9):. PubMed ID: 36146471
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of Q fever cellular and chloroform-methanol residue vaccines as skin test antigens in the sensitized guinea pig.
    Elliott JJ; Ruble DL; Zaucha GM; Jaax GP; Waag DM
    Acta Virol; 1998 Jun; 42(3):147-55. PubMed ID: 9842444
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Culture of C. burnetii from the dental pulp of experimentally infected guinea pigs.
    Aboudharam G; Drancourt M; Raoult D
    Microb Pathog; 2004 Jun; 36(6):349-50. PubMed ID: 15120161
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Study of Q fever in São Paulo. V. Comparison between the immune response of Jersey cattle and zebus to inoculation of Coxiella burnetii antigen].
    Netto AR; Nikitin T; Miguel O; Mizuno M; Ribeiro IF
    Rev Inst Med Trop Sao Paulo; 1968; 10(4):253-5. PubMed ID: 5692858
    [No Abstract]   [Full Text] [Related]  

  • 53. Mechanisms of protective immunogenicity of microbial vaccines: effects of cyclophosphamide pretreatment in Venezuelan encephalitis, Q fever and tularaemia.
    Ascher MS; Jahrling PB; Harrington DG; Kishimoto RA; McGann VG
    Clin Exp Immunol; 1980 Aug; 41(2):225-36. PubMed ID: 7438552
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthetic Particulate Subunit Vaccines for the Prevention of Q Fever.
    Sam G; Plain K; Chen S; Islam A; Westman ME; Marsh I; Stenos J; Graves SR; Rehm BHA
    Adv Healthc Mater; 2024 Mar; 13(7):e2302351. PubMed ID: 38198823
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alterations of immune functions induced by 12C6+ ion irradiation in mice.
    Xie Y; Zhang H; Wang YL; Zhou QM; Qiu R; Yuan ZG; Zhou GM
    Int J Radiat Biol; 2007 Sep; 83(9):577-81. PubMed ID: 17654099
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [On the immunogenicity of various phases of the Burneti rickettsia].
    Kudelina RI; Fedorova NI
    Zh Mikrobiol Epidemiol Immunobiol; 1967 May; 44(5):17-21. PubMed ID: 5617968
    [No Abstract]   [Full Text] [Related]  

  • 57. Development of local morphological changes after intradermal inoculation of Q-fever chemovaccine.
    Resl M; Sidorenko SV; Zhuljabin EI
    Acta Virol; 1989 Mar; 33(2):167-71. PubMed ID: 2569813
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Seroepidemiologic and occupational risk survey for Coxiella burnetii antibodies among US veterinarians.
    Whitney EA; Massung RF; Candee AJ; Ailes EC; Myers LM; Patterson NE; Berkelman RL
    Clin Infect Dis; 2009 Mar; 48(5):550-7. PubMed ID: 19191638
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of ultraviolet irradiation on the acquisition and expression of tick resistance in guinea-pigs.
    Nithiuthai S; Allen JR
    Immunology; 1984 Jan; 51(1):153-9. PubMed ID: 6690394
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protection of pigs from lethal challenge by a DNA vaccine based on an alphavirus replicon expressing the E2 glycoprotein of classical swine fever virus.
    Li N; Zhao JJ; Zhao HP; Sun Y; Zhu QH; Tong GZ; Qiu HJ
    J Virol Methods; 2007 Sep; 144(1-2):73-8. PubMed ID: 17499369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.